Barclays’s Adaptive Biotechnologies ADPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.22M | Buy |
362,634
+158,664
| +78% | +$1.85M | ﹤0.01% | 1740 |
|
2025
Q1 | $1.52M | Sell |
203,970
-62,096
| -23% | -$461K | ﹤0.01% | 2220 |
|
2024
Q4 | $1.6M | Buy |
266,066
+35,889
| +16% | +$215K | ﹤0.01% | 2357 |
|
2024
Q3 | $1.18M | Buy |
230,177
+137,936
| +150% | +$707K | ﹤0.01% | 2522 |
|
2024
Q2 | $333K | Sell |
92,241
-59,264
| -39% | -$214K | ﹤0.01% | 2760 |
|
2024
Q1 | $486K | Sell |
151,505
-76,350
| -34% | -$245K | ﹤0.01% | 2853 |
|
2023
Q4 | $1.12M | Buy |
227,855
+91,834
| +68% | +$450K | ﹤0.01% | 2536 |
|
2023
Q3 | $741K | Buy |
136,021
+11,112
| +9% | +$60.5K | ﹤0.01% | 2297 |
|
2023
Q2 | $838K | Sell |
124,909
-77,520
| -38% | -$520K | ﹤0.01% | 2263 |
|
2023
Q1 | $1.79M | Sell |
202,429
-396,135
| -66% | -$3.5M | ﹤0.01% | 1722 |
|
2022
Q4 | $4.57M | Buy |
598,564
+439,726
| +277% | +$3.36M | ﹤0.01% | 1164 |
|
2022
Q3 | $1.13M | Buy |
158,838
+85,119
| +115% | +$606K | ﹤0.01% | 2038 |
|
2022
Q2 | $596K | Buy |
73,719
+35,276
| +92% | +$285K | ﹤0.01% | 2457 |
|
2022
Q1 | $534K | Sell |
38,443
-297,365
| -89% | -$4.13M | ﹤0.01% | 2759 |
|
2021
Q4 | $9.42M | Buy |
335,808
+296,137
| +746% | +$8.31M | ﹤0.01% | 914 |
|
2021
Q3 | $1.35M | Buy |
39,671
+16,499
| +71% | +$560K | ﹤0.01% | 2087 |
|
2021
Q2 | $947K | Sell |
23,172
-45,918
| -66% | -$1.88M | ﹤0.01% | 2145 |
|
2021
Q1 | $2.78M | Sell |
69,090
-32,850
| -32% | -$1.32M | ﹤0.01% | 1630 |
|
2020
Q4 | $6.03M | Buy |
101,940
+101,852
| +115,741% | +$6.02M | ﹤0.01% | 940 |
|
2020
Q3 | $4K | Sell |
88
-23,381
| -100% | -$1.06M | ﹤0.01% | 3625 |
|
2020
Q2 | $1.14M | Buy |
23,469
+21,540
| +1,117% | +$1.04M | ﹤0.01% | 1842 |
|
2020
Q1 | $54K | Buy |
1,929
+1,623
| +530% | +$45.4K | ﹤0.01% | 3065 |
|
2019
Q4 | $9K | Sell |
306
-5,900
| -95% | -$174K | ﹤0.01% | 3730 |
|
2019
Q3 | $191K | Sell |
6,206
-8,125
| -57% | -$250K | ﹤0.01% | 3079 |
|
2019
Q2 | $693K | Buy |
+14,331
| New | +$693K | ﹤0.01% | 2556 |
|